(fifthQuint)Efficacy and Safety Of Spil's Estradiol Vaginal Tablet.

 Estradiol vaginal tablet is indicated for use in the treatment of symptoms of atrophic vaginitis due to estrogen deficiency.

 This is a randomized, observer blind, parallel groups, active and placebo controlled study to test the clinical endpoint bioequivalence of test product (Estradiol vaginal tablet, 10mcg of Sun Pharmaceutical Industries Ltd.

 India) relative to reference (Vagifem(R), Estradiol vaginal tablet, 10mcg estradiol of Novo Nordisk) in treatment of vulvar and vaginal atrophy.

 The patients will be administered with one tablet intravaginally daily for 14 days.

.

 Efficacy and Safety Of Spil's Estradiol Vaginal Tablet@highlight

Estradiol vaginal tablet is a tablet which hydrates upon contact with moisture, releasing 17ss-estradiol.

 The estradiol in estradiol vaginal tablet is chemically and biologically identical to the endogenous human estradiol and is therefore classified as a human estrogen.

 The purpose of this study is to demonstrate clinical endpoint bioequivalence of SPIL's Estradiol vaginal tablet, 10mcg estradiol to the reference listed drug (Vagifem(R))which is approved and marketed in the US.

